Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 6 open reading frame 15 (C6orf15) encodes a secreted protein primarily localized in the extracellular matrix and is predicted to participate in extracellular matrix composition and remodeling, potentially through its binding affinity for collagen V, fibronectin, and glycosaminoglycans[2][3]. Although its precise physiological function remains uncharacterized, recent research implicates C6orf15 in colorectal cancer progression, where its upregulation promotes epithelial–mesenchymal transition, increases cell invasiveness, and modulates fatty acid metabolism, likely via activation of the WNT/β-catenin signaling pathway[2]. It has been suggested as a biomarker for liver metastasis in colorectal cancer and is also associated with several autoimmune and skin disorders, but there are no approved drugs or targeted therapies for C6orf15 at this time[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 6 open reading frame 15 (C6orf15).